Related Category
Business Type
Indication As a source of energy in parenteral nutrition. In severe hypoglycaemia due to insulin excess or other causes. For reduction of cerebrospinal pressure and/or cerebral oedema due to delirium tremens or acute alcohol intoxication. Glucose injection 50% w/v is strongly hypertonic and is used partly bec more...
Purpose. Paracetamol is recommended as a first-line treatment for pain and fever in paediatric patients. Intravenous (IV) infusions are recommended to be Pack Size 100 ml Pack Type Bottle Drug Composition Paracetamol 100mg Brand Paramir-IV Manufacturer JOHNLEE Purpose. Paracetamol is recommended as a first-li more...
Pamidronate Disodium IV Infusion BP 30 mg & 60 mg is used in treatment of moderate to severe hypercalcemia associated with malignancy with or without bone metastases; treatment of moderate to severe Paget disease of bone; treatment of osteolytic bone lesions of multiple myeloma and bone metast more...
Paracetamol 10 mg/ml Solution for Infusion is indicated for the short-term treatment of moderate pain, especially following surgery, and for the short-term treatment of fever, when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when more...
Get Quotes from Verified Suppliers
Parataj 1000 MG Infusion is an antipyretic medicine that contains paracetamol as an active ingredient. It is used as first-line therapy for the treatment of fever and pain. It provides fast and effective relief from moderate to severe pain associated with/without fever. It decreases the intensity of pain sign more...
Paracetamol IP 1000mg is a commonly used medication to relieve pain and reduce fever. It is effective for conditions like headaches, muscle aches, toothaches, joint pain, and menstrual cramps, as well as for reducing fever caused by infections or illnesses. Paracetamol works by blocking certain chemicals in t more...
FDA grants regular approval to sacituzumab govitecan for triple-negative breast cancer.On April 7, 2021, the Food and Drug Administration granted regular approval to sacituzumab govitecan (Trodelvy, Immunomedics Inc.) for patients with unresectable locally advanced or metastatic triple-negative breast cancer more...
Connect with us
For Buyer 
For Seller 
Help 
